Involvement	O
of	O
Alu	B-DNA
sequences	I-DNA
in	O
the	O
cell-specific	O
regulation	O
of	O
transcription	O
of	O
the	O
gamma	B-protein
chain	I-protein
of	O
Fc	B-protein
and	O
T	B-protein
cell	I-protein
receptors	I-protein
.	O

The	O
Fc	B-protein
epsilon	I-protein
RI-gamma	I-protein
chains	I-protein
are	O
expressed	O
in	O
a	O
variety	O
of	O
hematopoietic	B-cell_type
cells	I-cell_type
where	O
they	O
play	O
a	O
critical	O
role	O
in	O
signal	O
transduction	O
.	O

They	O
are	O
part	O
of	O
the	O
high	B-protein
affinity	I-protein
IgE	I-protein
receptor	I-protein
in	O
mast	B-cell_type
cells	I-cell_type
,	O
basophils	B-cell_type
,	O
Langerhans	B-cell_type
cells	I-cell_type
,	O
and	O
possibly	O
other	O
cells	O
;	O
a	O
component	O
of	O
the	O
low	O
affinity	O
receptor	O
for	O
IgG	B-protein
(	O
Fc	B-protein
gamma	I-protein
RIIIA	I-protein
or	O
CD16	B-protein
)	O
in	O
natural	O
killer	B-cell_type
cells	I-cell_type
and	O
macrophages	B-cell_type
;	O
and	O
part	O
of	O
the	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
in	O
subsets	O
of	O
T	B-cell_type
cells	I-cell_type
.	O

Here	O
we	O
have	O
investigated	O
the	O
transcriptional	O
regulation	O
of	O
the	O
gamma	B-protein
chain	I-protein
gene	O
by	O
analyzing	O
the	O
2.5-kilobase	B-DNA
sequence	I-DNA
upstream	O
of	O
the	O
transcription	O
start	O
site	O
.	O

This	O
sequence	O
contains	O
a	O
promoter	B-DNA
specific	O
to	O
cells	B-cell_type
of	I-cell_type
hematopoietic	I-cell_type
lineage	I-cell_type
.	O

However	O
,	O
the	O
tissue	O
specificity	O
of	O
this	O
promoter	B-DNA
is	O
only	O
partial	O
because	O
it	O
is	O
active	O
in	O
all	O
of	O
the	O
hematopoietic	B-cell_type
cells	I-cell_type
tested	O
here	O
,	O
regardless	O
of	O
whether	O
they	O
constitutively	O
express	O
Fc	O
epsilon	O
RI-	O
gamma	B-protein
chain	I-protein
transcripts	O
.	O

We	O
have	O
identified	O
two	O
adjacent	O
cis-acting	O
regulatory	O
elements	O
,	O
both	O
of	O
which	O
are	O
part	O
of	O
an	O
Alu	O
repeat	O
.	O

The	O
first	O
(	O
-445/-366	O
)	O
is	O
a	O
positive	O
element	O
active	O
in	O
both	O
basophils	B-cell_type
and	O
T	B-cell_type
cells	I-cell_type
.	O

The	O
second	O
(	O
-365/-264	O
)	O
binds	O
to	O
nuclear	B-protein
factors	I-protein
,	O
which	O
appear	O
to	O
be	O
different	O
in	O
basophils	B-cell_type
and	O
T	B-cell_type
cells	I-cell_type
,	O
and	O
acts	O
as	O
a	O
negative	O
element	O
in	O
basophils	B-cell_type
and	O
as	O
a	O
positive	O
one	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Thus	O
,	O
this	O
Alu	B-DNA
repeat	I-DNA
(	O
90	O
%	O
identical	O
to	O
Alu	B-DNA
consensus	I-DNA
sequences	I-DNA
)	O
has	O
evolved	O
to	O
become	O
both	O
a	O
positive	O
and	O
negative	O
regulator	O
.	O

THE	NULL
JOURNAL	NULL
OF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

2	NULL
,	NULL
Issue	NULL
of	NULL
January	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

1355-1361	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Involvement	NULL
of	NULL
Alu	NULL
Sequences	NULL
in	NULL
the	NULL
Cell-specific	NULL
Regulation	NULL
of	NULL
Transcription	NULL
of	NULL
the	NULL
y	NULL
Chain	NULL
of	NULL
Fc	NULL
and	NULL
T	NULL
Cell	NULL
Receptors*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
August	NULL
18	NULL
,	NULL
1992	NULL
)	NULL
Anna	NULL
T.	NULL
Brinig	NULL
,	NULL
Gai	NULL
M.	NULL
Lee	NULL
,	NULL
and	NULL
Jean-Pierre	NULL
Kinet	NULL
From	NULL
the	NULL
Molecular	NULL
Allergy	NULL
and	NULL
Immunology	NULL
Section	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Rockville	NULL
,	NULL
Maryland	NULL
20852	NULL
The	NULL
FeeRI-y	NULL
chains	NULL
are	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
hematopoietic	NULL
cells	NULL
where	NULL
they	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

They	NULL
are	NULL
part	NULL
of	NULL
the	NULL
high	NULL
affinity	NULL
IgE	NULL
receptor	NULL
in	NULL
mast	NULL
cells	NULL
,	NULL
basophils	NULL
,	NULL
Langerhans	NULL
cells	NULL
,	NULL
and	NULL
possibly	NULL
other	NULL
cells	NULL
;	NULL
a	NULL
component	NULL
of	NULL
the	NULL
low	NULL
affinity	NULL
receptor	NULL
for	NULL
IgG	NULL
(	NULL
FeyRIIIA	NULL
or	NULL
CD16	NULL
)	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
and	NULL
macrophages	NULL
;	NULL
and	NULL
part	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
in	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Here	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
y	NULL
chain	NULL
gene	NULL
by	NULL
analyzing	NULL
the	NULL
2.5-kilobase	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

This	NULL
sequence	NULL
contains	NULL
a	NULL
promoter	NULL
specific	NULL
to	NULL
cells	NULL
of	NULL
hematopoietic	NULL
lineage	NULL
.	NULL

However	NULL
,	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
this	NULL
promoter	NULL
is	NULL
only	NULL
partial	NULL
because	NULL
it	NULL
is	NULL
active	NULL
in	NULL
all	NULL
of	NULL
the	NULL
hematopoietic	NULL
cells	NULL
tested	NULL
here	NULL
,	NULL
regardless	NULL
of	NULL
whether	NULL
they	NULL
constitutively	NULL
express	NULL
FeeRI-	NULL
y	NULL
chain	NULL
transcripts	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
two	NULL
adjacent	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
part	NULL
of	NULL
an	NULL
Alu	NULL
repeat	NULL
.	NULL

The	NULL
first	NULL
(	NULL
-445/-366	NULL
)	NULL
is	NULL
a	NULL
positive	NULL
element	NULL
active	NULL
in	NULL
both	NULL
basophils	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
second	NULL
(	NULL
-365/-264	NULL
)	NULL
binds	NULL
to	NULL
nuclear	NULL
factors	NULL
,	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
different	NULL
in	NULL
basophils	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
negative	NULL
element	NULL
in	NULL
basophils	NULL
and	NULL
as	NULL
a	NULL
positive	NULL
one	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
Alu	NULL
repeat	NULL
(	NULL
90	NULL
%	NULL
identical	NULL
to	NULL
Alu	NULL
consensus	NULL
sequences	NULL
)	NULL
has	NULL
evolved	NULL
to	NULL
become	NULL
both	NULL
a	NULL
positive	NULL
and	NULL
negative	NULL
regulator	NULL
.	NULL

The	NULL
y	NULL
chains	NULL
initially	NULL
described	NULL
as	NULL
subunits	NULL
of	NULL
the	NULL
high	NULL
affinity	NULL
IgE	NULL
receptor	NULL
(	NULL
FeeRI	NULL
)	NULL
®	NULL
are	NULL
expressed	NULL
in	NULL
various	NULL
hematopoietic	NULL
cells	NULL
and	NULL
are	NULL
part	NULL
of	NULL
several	NULL
receptor	NULL
multimeric	NULL
complexes	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Homodimers	NULL
of	NULL
y	NULL
chains	NULL
,	NULL
together	NULL
with	NULL
an	NULL
«	NULL
and	NULL
a	NULL
8	NULL
chain	NULL
,	NULL
form	NULL
the	NULL
tetrameric	NULL
FeeRI	NULL
receptor	NULL
in	NULL
mast	NULL
cells	NULL
,	NULL
basophils	NULL
,	NULL
and	NULL
Langerhans	NULL
cells	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

The	NULL
same	NULL
y7	NULL
homodimers	NULL
also	NULL
associate	NULL
with	NULL
the	NULL
low	NULL
affinity	NULL
receptor	NULL
for	NULL
IgG	NULL
(	NULL
FeyRIII	NULL
,	NULL
CD16	NULL
)	NULL
in	NULL
mast	NULL
cells	NULL
,	NULL
basophils	NULL
,	NULL
and	NULL
monocytes	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
forming	NULL
disulfide-linked	NULL
homodimers	NULL
,	NULL
the	NULL
y	NULL
chains	NULL
interact	NULL
with	NULL
two	NULL
other	NULL
homologous	NULL
proteins	NULL
,	NULL
the	NULL
¢	NULL
and	NULL
7	NULL
chains	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

These	NULL
three	NULL
chains	NULL
generate	NULL
six	NULL
different	NULL
dimers	NULL
,	NULL
the	NULL
yy	NULL
,	NULL
{	NULL
{	NULL
,	NULL
and	NULL
»	NULL
»	NULL
homodimers	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
``	NULL
/EMBL	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
1LO3533	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
sent	NULL
:	NULL
12441	NULL
Parklawn	NULL
Dr.	NULL
,	NULL
Twinbrook	NULL
II	NULL
,	NULL
Rm	NULL
.	NULL

108	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
FceRI	NULL
,	NULL
high	NULL
affinity	NULL
receptor	NULL
for	NULL
immunoglobulin	NULL
E	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
uF	NULL
,	NULL
mi-crofarads	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
RBL	NULL
,	NULL
rat	NULL
basophilic	NULL
leukemia	NULL
;	NULL
Alu	NULL
repeat	NULL
,	NULL
major	NULL
interdisperse	NULL
repetitive	NULL
nucleotide	NULL
sequence	NULL
in	NULL
the	NULL
mammalian	NULL
group	NULL
.	NULL

and	NULL
the	NULL
y	NULL
{	NULL
,	NULL
y7	NULL
,	NULL
and	NULL
{	NULL
»	NULL
heterodimers	NULL
,	NULL
all	NULL
of	NULL
which	NULL
associate	NULL
with	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
in	NULL
some	NULL
subsets	NULL
of	NULL
T	NULL
lymphocytes	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

The	NULL
y7	NULL
,	NULL
{	NULL
{	NULL
homodimers	NULL
and	NULL
the	NULL
y	NULL
{	NULL
heterodimers	NULL
are	NULL
also	NULL
part	NULL
of	NULL
the	NULL
low	NULL
affinity	NULL
IgG	NULL
receptor	NULL
(	NULL
CD16-FceyRIII	NULL
)	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
(	NULL
11-15	NULL
)	NULL
.	NULL

The	NULL
y	NULL
,	NULL
¢	NULL
,	NULL
and	NULL
1	NULL
chains	NULL
belong	NULL
to	NULL
the	NULL
same	NULL
family	NULL
of	NULL
mole-cules	NULL
.	NULL

Their	NULL
respective	NULL
genes	NULL
show	NULL
a	NULL
similar	NULL
genomic	NULL
organization	NULL
and	NULL
are	NULL
located	NULL
on	NULL
mouse	NULL
and	NULL
human	NULL
chromosome	NULL
1	NULL
(	NULL
16-23	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
they	NULL
contain	NULL
homologous	NULL
amino	NULL
acid	NULL
motifs	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
critical	NULL
to	NULL
the	NULL
initiation	NULL
of	NULL
receptor-mediated	NULL
signal	NULL
transduction	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
our	NULL
laboratory	NULL
has	NULL
characterized	NULL
cDNA	NULL
and	NULL
genomic	NULL
clones	NULL
for	NULL
the	NULL
human	NULL
FeeRI-y	NULL
chain	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
gene	NULL
consists	NULL
of	NULL
five	NULL
exons	NULL
and	NULL
spans	NULL
4	NULL
kilobases	NULL
.	NULL

There	NULL
is	NULL
a	NULL
major	NULL
start	NULL
site	NULL
localized	NULL
25	NULL
base	NULL
pairs	NULL
upstream	NULL
of	NULL
the	NULL
start	NULL
codon	NULL
,	NULL
but	NULL
a	NULL
few	NULL
additional	NULL
start	NULL
sites	NULL
are	NULL
also	NULL
present	NULL
.	NULL

The	NULL
gene	NULL
does	NULL
not	NULL
show	NULL
a	NULL
typical	NULL
TATA	NULL
box	NULL
but	NULL
contains	NULL
inverted	NULL
CAAT	NULL
and	NULL
GC	NULL
boxes	NULL
at	NULL
positions	NULL
-199	NULL
and	NULL
-135	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
gene	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
such	NULL
as	NULL
basophils	NULL
(	NULL
1	NULL
)	NULL
but	NULL
is	NULL
only	NULL
expressed	NULL
in	NULL
subsets	NULL
of	NULL
others	NULL
cells	NULL
such	NULL
as	NULL
T	NULL
lymphocytes	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
5	NULL
region	NULL
and	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
FeeRI-y	NULL
gene	NULL
and	NULL
have	NULL
detected	NULL
the	NULL
presence	NULL
of	NULL
positive	NULL
and	NULL
negative	NULL
cis-acting	NULL
elements	NULL
.	NULL

We	NULL
show	NULL
that	NULL
the	NULL
promoter	NULL
is	NULL
hematopoietic-specific	NULL
and	NULL
that	NULL
Alu	NULL
sequences	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
transcrip-tion	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Sequencing	NULL
the	NULL
5'-Flanking	NULL
Region	NULL
of	NULL
the	NULL
Human	NULL
FceRI-y	NULL
Gene-A	NULL
genomic	NULL
clone	NULL
longer	NULL
than	NULL
the	NULL
one	NULL
previously	NULL
described	NULL
and	NULL
sequenced	NULL
(	NULL
16	NULL
)	NULL
was	NULL
isolated	NULL
.	NULL

A	NULL
5-kilobase	NULL
Sall	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
pBS+	NULL
vector	NULL
(	NULL
Stratagene	NULL
)	NULL
,	NULL
and	NULL
a	NULL
restriction	NULL
map	NULL
was	NULL
estab-lished	NULL
.	NULL

A	NULL
2.2-kilobase	NULL
HindlII/BgilI	NULL
fragment	NULL
corresponding	NULL
to	NULL
the	NULL
5	NULL
``	NULL
sequence	NULL
of	NULL
the	NULL
gene	NULL
was	NULL
isolated	NULL
,	NULL
subcloned	NULL
,	NULL
and	NULL
sequenced	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
using	NULL
21-base	NULL
pair	NULL
unlabeled	NULL
oligonucleotide	NULL
primers	NULL
as	NULL
described	NULL
before	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Plasmid	NULL
Construction-DNA	NULL
from	NULL
a	NULL
genomic	NULL
clone	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
in	NULL
a	NULL
polymerase	NULL
chain	NULL
reaction	NULL
to	NULL
generate	NULL
various	NULL
fragments	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
FeeRI-y	NULL
gene	NULL
.	NULL

Oligonucleotides	NULL
(	NULL
24-mer	NULL
)	NULL
starting	NULL
at	NULL
positions	NULL
-445	NULL
,	NULL
-295	NULL
,	NULL
~237	NULL
,	NULL
-161	NULL
,	NULL
~95	NULL
,	NULL
and	NULL
-54	NULL
were	NULL
chosen	NULL
as	NULL
5	NULL
primer	NULL
,	NULL
and	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
was	NULL
the	NULL
same	NULL
oligonucleotide	NULL
ending	NULL
at	NULL
position	NULL
+26	NULL
.	NULL

Convenient	NULL
restriction	NULL
sites	NULL
were	NULL
added	NULL
to	NULL
each	NULL
oligonucleotide	NULL
.	NULL

The	NULL
polymerase	NULL
chain	NULL
reactions	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
in	NULL
a	NULL
100-ul	NULL
reaction	NULL
volume	NULL
containing	NULL
1.5	NULL
mm	NULL
MgCl	NULL
;	NULL
,	NULL
50	NULL
pmol	NULL
of	NULL
primers	NULL
,	NULL
1	NULL
unit	NULL
of	NULL
Taq	NULL
polym-erase	NULL
,	NULL
and	NULL
200	NULL
uM	NULL
dNTPs	NULL
.	NULL

The	NULL
polymerase	NULL
chain	NULL
reaction	NULL
products	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
Xbal	NULL
sites	NULL
of	NULL
the	NULL
pCAT-basic	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
-2382/+26	NULL
construct	NULL
was	NULL
generated	NULL
by	NULL
ligation	NULL
of	NULL
the	NULL
-2382/	NULL
-180	NULL
restricted	NULL
fragment	NULL
into	NULL
HindIII	NULL
and	NULL
BeilI	NULL
sites	NULL
of	NULL
the	NULL
-445	NULL
construct	NULL
.	NULL

The	NULL
~1631	NULL
,	NULL
~1296	NULL
,	NULL
and	NULL
-365	NULL
CAT	NULL
constructs	NULL
were	NULL
generated	NULL
by	NULL
excising	NULL
the	NULL
HindIII	NULL
and	NULL
Ciel	NULL
,	NULL
HindIII	NULL
and	NULL
PpuMI	NULL
,	NULL
HindlIl	NULL
,	NULL
and	NULL
Acc	NULL
!	NULL

fragments	NULL
respectively	NULL
,	NULL
from	NULL
the	NULL
-2382	NULL
construct	NULL
prior	NULL
to	NULL
religation	NULL
.	NULL

The	NULL
-445	NULL
gap	NULL
(	NULL
-365/-264	NULL
)	NULL
CAT	NULL
construct	NULL
was	NULL
obtained	NULL
by	NULL
a	NULL
two	NULL
1355	NULL
1356	NULL
step	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

The	NULL
-445/-264	NULL
(	NULL
HindIlI/Accl	NULL
)	NULL
fragment	NULL
was	NULL
inserted	NULL
upstream	NULL
(	NULL
Bg/Il	NULL
)	NULL
or	NULL
downstream	NULL
(	NULL
BamHI	NULL
)	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
in	NULL
the	NULL
pCAT-promoter	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Standard	NULL
procedures	NULL
were	NULL
used	NULL
in	NULL
all	NULL
plasmid	NULL
constructions	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Both	NULL
strands	NULL
of	NULL
each	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
as	NULL
above	NULL
.	NULL

Cells-The	NULL
CEM-CM-3	NULL
,	NULL
Jurkat	NULL
,	NULL
HeLa	NULL
,	NULL
COS-7	NULL
,	NULL
U937	NULL
,	NULL
HL-60	NULL
cell	NULL
lines	NULL
were	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
.	NULL

The	NULL
human	NULL
basophilic	NULL
KU812	NULL
cell	NULL
line	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
K.	NULL
Kishi	NULL
(	NULL
25	NULL
)	NULL
;	NULL
the	NULL
Daudi	NULL
cell	NULL
line	NULL
was	NULL
from	NULL
Dr.	NULL
M.	NULL
Schwabe	NULL
NCI-Frederick	NULL
,	NULL
MD	NULL
;	NULL
the	NULL
NK	NULL
3.3	NULL
cell	NULL
line	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
J.	NULL
Kornbluth	NULL
(	NULL
26	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
propagated	NULL
in	NULL
the	NULL
recommended	NULL
media	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
and	NULL
95	NULL
%	NULL
air	NULL
.	NULL

RBL-2H3	NULL
cells	NULL
were	NULL
maintained	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Transfection-Cells	NULL
growing	NULL
in	NULL
suspension	NULL
were	NULL
transfected	NULL
while	NULL
in	NULL
exponential	NULL
growth	NULL
,	NULL
whereas	NULL
adherent	NULL
cells	NULL
were	NULL
transfected	NULL
when	NULL
70-80	NULL
%	NULL
confluent	NULL
.	NULL

DNA	NULL
was	NULL
transfected	NULL
into	NULL
HeLa	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
COS-7	NULL
cells	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
24	NULL
,	NULL
28	NULL
)	NULL
.	NULL

The	NULL
other	NULL
cell	NULL
lines	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
apparatus	NULL
.	NULL

500	NULL
wl	NULL
of	NULL
the	NULL
various	NULL
cells	NULL
in	NULL
complete	NULL
medium	NULL
was	NULL
electroporated	NULL
using	NULL
the	NULL
following	NULL
conditions	NULL
:	NULL
5	NULL
x	NULL
10°	NULL
Jurkat	NULL
cells	NULL
,	NULL
300	NULL
volts	NULL
and	NULL
500	NULL
F	NULL
;	NULL
5	NULL
x	NULL
10°	NULL
CEM-CM-3	NULL
cells	NULL
,	NULL
200	NULL
volts	NULL
and	NULL
960	NULL
uF	NULL
;	NULL
1	NULL
x	NULL
10	NULL
``	NULL
RBL-2H3	NULL
cells	NULL
,	NULL
250	NULL
volts	NULL
and	NULL
500	NULL
uF	NULL
;	NULL
1	NULL
x	NULL
10°	NULL
KU812	NULL
cells	NULL
,	NULL
330	NULL
volts	NULL
and	NULL
960	NULL
uF	NULL
.	NULL

Cotransfection	NULL
of	NULL
pCMV-B-galactosidase	NULL
plasmid	NULL
(	NULL
29	NULL
)	NULL
,	NULL
which	NULL
comprises	NULL
an	NULL
Escherichia	NULL
coli	NULL
LacZ	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
and	NULL
to	NULL
determine	NULL
the	NULL
best	NULL
conditions	NULL
for	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
phosphate	NULL
buffered	NULL
saline	NULL
,	NULL
and	NULL
lysed	NULL
by	NULL
repeated	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
in	NULL
250	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
.	NULL

Enzyme	NULL
Assays-The	NULL
-galactosidase	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
with	NULL
10-30	NULL
ug	NULL
of	NULL
protein	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
in	NULL
cell	NULL
lysates	NULL
,	NULL
normalized	NULL
for	NULL
protein	NULL
concentrations	NULL
and	NULL
for	NULL
unit	NULL
of	NULL
B-galactosidase	NULL
,	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
slight	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
short	NULL
,	NULL
the	NULL
acetylated	NULL
chloramphenicol	NULL
was	NULL
separated	NULL
from	NULL
the	NULL
nonacetylated	NULL
form	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
and	NULL
developed	NULL
in	NULL
chloroform/methanol	NULL
(	NULL
95:5	NULL
,	NULL
v/v	NULL
)	NULL
.	NULL

The	NULL
radioactivity	NULL
of	NULL
each	NULL
acetylated	NULL
and	NULL
nonacetylated	NULL
spot	NULL
was	NULL
directly	NULL
determined	NULL
with	NULL
the	NULL
Ambis	NULL
radioanalytic	NULL
imaging	NULL
system	NULL
.	NULL

CAT	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
acetylated	NULL
forms/total	NULL
X	NULL
100/100	NULL
units	NULL
of	NULL
-galactosidase	NULL
.	NULL

Every	NULL
transfection	NULL
experiment	NULL
was	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
(	NULL
*	NULL
S.E	NULL
.	NULL

or	NULL
S.D	NULL
as	NULL
indicated	NULL
)	NULL
of	NULL
at	NULL
least	NULL
three	NULL
different	NULL
transfections	NULL
for	NULL
each	NULL
construct	NULL
and	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
.	NULL

Nuclear	NULL
Extract	NULL
Preparation-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
outlined	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
32	NULL
)	NULL
.	NULL

Buffers	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
contained	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
and	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
to	NULL
minimize	NULL
proteolysis	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
in	NULL
5	NULL
volumes	NULL
of	NULL
buffer	NULL
A	NULL
.	NULL

After	NULL
10	NULL
min	NULL
cell	NULL
membranes	NULL
were	NULL
disrupted	NULL
by	NULL
12	NULL
strokes	NULL
of	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
(	NULL
pestle	NULL
B	NULL
)	NULL
,	NULL
and	NULL
the	NULL
intact	NULL
nuclei	NULL
were	NULL
pelleted	NULL
for	NULL
20	NULL
min	NULL
in	NULL
a	NULL
microcentrifuge	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
broken	NULL
by	NULL
10	NULL
strokes	NULL
of	NULL
the	NULL
Dounce	NULL
homogenizer	NULL
in	NULL
2	NULL
volumes	NULL
of	NULL
buffer	NULL
C	NULL
and	NULL
then	NULL
stirred	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
nuclear	NULL
extract	NULL
was	NULL
then	NULL
clarified	NULL
by	NULL
centrifugation	NULL
(	NULL
as	NULL
above	NULL
)	NULL
and	NULL
dialyzed	NULL
against	NULL
buffer	NULL
D	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
total	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
nuclear	NULL
extract	NULL
were	NULL
used	NULL
immediately	NULL
or	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
for	NULL
later	NULL
use	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSAs	NULL
)	NULL
-Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
33	NULL
)	NULL
with	NULL
modifi-cations	NULL
.	NULL

The	NULL
double-stranded	NULL
DNA	NULL
fragments	NULL
spanning	NULL
the	NULL
sequences	NULL
-445/~180	NULL
,	NULL
-445/-264	NULL
,	NULL
and	NULL
-445/-365	NULL
of	NULL
the	NULL
y	NULL
gene	NULL
were	NULL
generated	NULL
by	NULL
enzymatic	NULL
digestion	NULL
and	NULL
isolated	NULL
by	NULL
standard	NULL
techniques	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
fragments	NULL
were	NULL
end	NULL
labeled	NULL
using	NULL
[	NULL
«	NULL
-*P	NULL
]	NULL
ATP	NULL
and	NULL
[	NULL
«	NULL
-*P	NULL
]	NULL
GTP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
Corp.	NULL
)	NULL
by	NULL
Klenow-large	NULL
fragment	NULL
polymerase	NULL
.	NULL

The	NULL
probe	NULL
,	NULL
spanning	NULL
the	NULL
region	NULL
-366/	NULL
--	NULL
290	NULL
was	NULL
generated	NULL
by	NULL
synthesizing	NULL
two	NULL
complementary	NULL
77-mer	NULL
oligonucleotides	NULL
and	NULL
by	NULL
annealing	NULL
the	NULL
two	NULL
oligonucleotides	NULL
at	NULL
an	NULL
equimolar	NULL
ratio	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
150	NULL
mM	NULL
NaCl	NULL
.	NULL

The	NULL
resultant	NULL
double-stranded	NULL
synthetic	NULL
oligonucleotide	NULL
was	NULL
gel	NULL
purified	NULL
on	NULL
a	NULL
12	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
subsequently	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-*P	NULL
]	NULL
JATP	NULL
and	NULL
T4	NULL
kinase	NULL
.	NULL

All	NULL
probes	NULL
were	NULL
purified	NULL
twice	NULL
over	NULL
a	NULL
Sephadex	NULL
G-25	NULL
column	NULL
.	NULL

The	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
used	NULL
for	NULL
competition	NULL
experiments	NULL
,	NULL
including	NULL
those	NULL
corresponding	NULL
to	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
NF-kB	NULL
(	NULL
84	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
35	NULL
)	NULL
,	NULL
were	NULL
prepared	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
poly	NULL
(	NULL
dA	NULL
)	NULL
-poly	NULL
(	NULL
dT	NULL
)	NULL
double-stranded	NULL
oligonucleotide	NULL
was	NULL
purchased	NULL
from	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
Inc	NULL
.	NULL

Binding	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
binding	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
60	NULL
mM	NULL
KC1	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
FeeRI-	NULL
»	NULL
y	NULL
Chain	NULL
Gene	NULL
1	NULL
mM	NULL
MgCl	NULL
»	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
about	NULL
0.5-1	NULL
ng	NULL
of	NULL
P	NULL
-labeled	NULL
DNA	NULL
fragment	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cpm	NULL
)	NULL
,	NULL
1	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
or	NULL
poly	NULL
(	NULL
dG	NULL
-	NULL
dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
and	NULL
2-30	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
.	NULL

Since	NULL
the	NULL
~366/-290	NULL
sequence	NULL
is	NULL
an	NULL
AT-rich	NULL
region	NULL
and	NULL
contains	NULL
23	NULL
adenines	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
with	NULL
this	NULL
probe	NULL
using	NULL
two	NULL
different	NULL
nonspecific	NULL
polyanion	NULL
competitors	NULL
(	NULL
poly	NULL
(	NULL
dI	NULL
-dC	NULL
)	NULL
and	NULL
poly	NULL
(	NULL
dG	NULL
-dC	NULL
)	NULL
)	NULL
to	NULL
unmask	NULL
complexes	NULL
which	NULL
would	NULL
be	NULL
undetectable	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
the	NULL
100-	NULL
or	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
5	NULL
min	NULL
before	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Extracts	NULL
and	NULL
probes	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
analyzed	NULL
either	NULL
on	NULL
a	NULL
5	NULL
or	NULL
a	NULL
8	NULL
%	NULL
polyacrylamide	NULL
nondenaturing	NULL
0.5	NULL
x	NULL
TBE	NULL
gel	NULL
(	NULL
acrylamide	NULL
:	NULL
bisacrylamide	NULL
ratio	NULL
of	NULL
38:2	NULL
)	NULL
depending	NULL
on	NULL
the	NULL
length	NULL
of	NULL
the	NULL
probes	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR-2	NULL
film	NULL
without	NULL
intensifying	NULL
screens	NULL
for	NULL
a	NULL
few	NULL
hours	NULL
or	NULL
overnight	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Consensus	NULL
Sequences	NULL
for	NULL
cis-Acting	NULL
Elements	NULL
in	NULL
the	NULL
5'-Flanking	NULL
Region	NULL
of	NULL
the	NULL
Human	NULL
FeeRI-y	NULL
Gene-As	NULL
a	NULL
first	NULL
step	NULL
in	NULL
the	NULL
characterization	NULL
of	NULL
the	NULL
regulatory	NULL
sequences	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
human	NULL
FceeRI-y	NULL
chain	NULL
gene	NULL
,	NULL
we	NULL
completed	NULL
the	NULL
sequencing	NULL
of	NULL
the	NULL
5	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
from	NULL
a	NULL
previously	NULL
described	NULL
genomic	NULL
clone	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

This	NULL
allowed	NULL
us	NULL
to	NULL
localize	NULL
a	NULL
number	NULL
of	NULL
consensus	NULL
sequences	NULL
for	NULL
potential	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
among	NULL
which	NULL
are	NULL
mast-cell	NULL
specific	NULL
elements	NULL
(	NULL
GATA	NULL
)	NULL
,	NULL
T	NULL
cell-specific	NULL
elements	NULL
(	NULL
Lyf-1	NULL
,	NULL
CTF-1	NULL
)	NULL
,	NULL
SP-1	NULL
sites	NULL
,	NULL
an	NULL
inverted	NULL
CAAT	NULL
box	NULL
,	NULL
several	NULL
y-interferon-	NULL
and	NULL
six	NULL
interleukin-6-re-sponsive	NULL
elements	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
y-interferon	NULL
elements	NULL
are	NULL
likely	NULL
involved	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
the	NULL
FeeRI-y	NULL
mRNA	NULL
levels	NULL
induced	NULL
by	NULL
y-interferon	NULL
in	NULL
purified	NULL
monocytes	NULL
and	NULL
in	NULL
the	NULL
U937	NULL
cell	NULL
line	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
identified	NULL
two	NULL
Alu	NULL
repeats	NULL
,	NULL
one	NULL
between	NULL
-2131	NULL
and	NULL
-2358	NULL
and	NULL
another	NULL
between	NULL
-313	NULL
and	NULL
-582	NULL
from	NULL
the	NULL
ATG	NULL
start	NULL
codon	NULL
(	NULL
see	NULL
also	NULL
below	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
Hematopoietic-specific	NULL
Promoter-To	NULL
identify	NULL
the	NULL
important	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
we	NULL
inserted	NULL
various	NULL
fragments	NULL
in	NULL
an	NULL
expression	NULL
vector	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
and	NULL
analyzed	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
various	NULL
deletions	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

Cotransfection	NULL
of	NULL
a	NULL
pCMV-B-galactosidase	NULL
plasmid	NULL
with	NULL
the	NULL
CAT	NULL
constructs	NULL
allowed	NULL
the	NULL
systematic	NULL
monitoring	NULL
of	NULL
the	NULL
transfection	NULL
efficiency	NULL
by	NULL
enzymatic	NULL
assay	NULL
.	NULL

The	NULL
rationale	NULL
of	NULL
the	NULL
different	NULL
deletion	NULL
constructs	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
is	NULL
as	NULL
follows	NULL
.	NULL

The	NULL
-95	NULL
construct	NULL
ends	NULL
3	NULL
'	NULL
of	NULL
an	NULL
SP-1	NULL
site	NULL
,	NULL
the	NULL
-161	NULL
construct	NULL
contains	NULL
this	NULL
SP-1	NULL
site	NULL
,	NULL
the	NULL
-237	NULL
construct	NULL
contains	NULL
the	NULL
inverted	NULL
CAAT	NULL
box	NULL
,	NULL
and	NULL
the	NULL
-295	NULL
construct	NULL
ends	NULL
3	NULL
``	NULL
of	NULL
a	NULL
stretch	NULL
of	NULL
23	NULL
consecutive	NULL
adenines	NULL
.	NULL

The	NULL
remaining	NULL
constructs	NULL
were	NULL
generated	NULL
from	NULL
convenient	NULL
enzymatic	NULL
restriction	NULL
sites	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
the	NULL
relative	NULL
CAT	NULL
activity	NULL
in	NULL
rat	NULL
basophilic	NULL
leukemia	NULL
cells	NULL
(	NULL
RBL-2H3	NULL
)	NULL
,	NULL
in	NULL
the	NULL
human	NULL
basophilic	NULL
cell	NULL
line	NULL
KUS12	NULL
,	NULL
and	NULL
in	NULL
non-hematopoietic	NULL
HeLa	NULL
cells	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
.	NULL

A	NULL
similar	NULL
analysis	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
the	NULL
CEM-CM-3	NULL
and	NULL
the	NULL
Jurkat	NULL
cell	NULL
lines	NULL
)	NULL
and	NULL
HeLa	NULL
cells	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
.	NULL

No	NULL
activity	NULL
is	NULL
detected	NULL
in	NULL
transfected	NULL
HeLa	NULL
cells	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
construct	NULL
and	NULL
despite	NULL
a	NULL
high	NULL
level	NULL
of	NULL
transfection	NULL
effi-ciency	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
-2382	NULL
construct	NULL
shows	NULL
a	NULL
substantial	NULL
activity	NULL
in	NULL
basophils	NULL
(	NULL
7.4	NULL
%	NULL
)	NULL
and	NULL
a	NULL
basal	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
1.17	NULL
%	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
-1637	NULL
construct	NULL
has	NULL
no	NULL
activity	NULL
in	NULL
either	NULL
cell	NULL
type	NULL
with	NULL
the	NULL
possible	NULL
exception	NULL
of	NULL
KU812	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
a	NULL
weak	NULL
activity	NULL
is	NULL
detected	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
~1296	NULL
construct	NULL
shows	NULL
an	NULL
activity	NULL
higher	NULL
than	NULL
the	NULL
one	NULL
observed	NULL
for	NULL
the	NULL
-1637	NULL
construct	NULL
,	NULL
except	NULL
again	NULL
in	NULL
KUS812	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
promoter	NULL
is	NULL
active	NULL
in	NULL
basophils	NULL
and	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
non-hematopoietic	NULL
cells	NULL
;	NULL
that	NULL
the	NULL
sequence	NULL
between	NULL
-1296	NULL
and	NULL
-1631	NULL
contains	NULL
a	NULL
*	NULL
A.	NULL
Brini	NULL
and	NULL
J.-P.	NULL
Kinet	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
FeeRI-y	NULL
Chain	NULL
Gene	NULL
neeg	NULL
)	NULL
A	NULL
cee	NULL
reercoreea	NULL
corcancoon	NULL
tormagorer	NULL
crecmaccac	NULL
ferercores	NULL
erfomecea	NULL
rrorcoreco	NULL
rraczcicoe	NULL
oacraccren	NULL
ca	NULL
tr233	NULL
__	NULL
-2183	NULL
acccaccace	NULL
acooocager	NULL
aarermiora	NULL
TIHITAGTAG	NULL
Toacrerorm	NULL
coocaeccre	NULL
erermeanca	NULL
CCreACCTCT_	NULL
Abd	NULL
Aut	NULL
cane	NULL
-an	NULL
~2003	NULL
accrcadcen	NULL
coomaGtee	NULL
resaarTaCa	NULL
aottortma	NULL
tercccarke	NULL
Crorccrorr	NULL
Aut	NULL
Key	NULL
cri	NULL
22033	NULL
+1983	NULL
rraczeacte	NULL
acarerooor	NULL
TractCrcce	NULL
rorcootea	NULL
réraerecen	NULL
Gacceetace	NULL
AcACAGAGTT	NULL
TGGBIﬁET	NULL
ars	NULL
ciss	NULL
)	NULL
rrarrertae	NULL
scccrertze	NULL
crorertcas	NULL
AGTCACTGAT	NULL
Textchert	NULL
?	NULL

crorceoom	NULL
Ccaaoticer	NULL
CCaGGaccca	NULL
-1632	NULL
cares	NULL
catreasoer	NULL
cocmacorhn	NULL
SoncaGohce	NULL
GoraGGhaaA	NULL
GAE-CCAxlAJGT	NULL
AGAGTAGGTA	NULL
GCTaARG	NULL
GAAKA	NULL
satcrtzaac	NULL
AmAZAGCTCA	NULL
<	NULL
a	NULL
+1733	NULL
creed	NULL
arazatanin	NULL
cacnrtonar	NULL
aoacorttze	NULL
sroseacron	NULL
amaathcior	NULL
rchrorrant	NULL
acacaercre	NULL
accomeorr	NULL
ericorronh	NULL
11632	NULL
11583	NULL
cacaongact	NULL
coresraete	NULL
roxtoscree	NULL
MGACACGGTT	NULL
comortTto	NULL
cmggglncn	NULL
SET	NULL
miss	NULL
:	NULL
aas	NULL
cersramera	NULL
GAMTTAMACC	NULL
TomertTcor	NULL
aroaorert	NULL
crticrcere	NULL
Coacertoca	NULL
aotertAncr	NULL
AncaTToTIG	NULL
-1433	NULL
11383	NULL
exeeomasce	NULL
roormzGGAc	NULL
accoacacat	NULL
ortoschcar	NULL
arcorrecca	NULL
rohrAGoTac	NULL
Gaooccrat	NULL
GrotAGzaOA	NULL
eri	NULL
11333	NULL
11283	NULL
cormtcerhs	NULL
acaracshor	NULL
tcoseacace	NULL
reaccathes	NULL
cchrencare	NULL
Shcroosore	NULL
Crcantornt	NULL
-1233	NULL
-1183	NULL
TeaGcacaor	NULL
aatocorter	NULL
dontorross	NULL
raacaccher	NULL
achicacona	NULL
FAATIAMGTMC	NULL
Tcorccarce	NULL
suss	NULL
-1083	NULL
Tercacerao	NULL
oraccemen	NULL
marrorattr	NULL
GoacaAstac	NULL
AtcGGrGaG¢	NULL
corr	NULL
512C	NULL
cocerscera_Teaccrzert	NULL
crerduacte	NULL
se	NULL
arn	NULL
1983	NULL
terrcoreac	NULL
toomartas	NULL
cererarore	NULL
rererorers	NULL
reretorera	NULL
rerGrarore	NULL
matertcrto	NULL
racacttooc	NULL
Torcascorr	NULL
rorarccate	NULL
99	NULL
-ssa	NULL
Tacramman	NULL
coaaratth	NULL
Gccarertcs	NULL
cecceetace	NULL
ectamerte	NULL
Grorercasr	NULL
Atorzaozor	NULL
Coricacreo	NULL
ce32	NULL
<	NULL
3	NULL
cactorame	NULL
erancamtor	NULL
rccamtcers	NULL
rracarIChG	NULL
teacorerta	NULL
coaaterttc	NULL
erocreorer	NULL
conceccor	NULL
:	NULL
crersacrcr	NULL
am	NULL
nes2	NULL
Tercertice	NULL
rerrereras	NULL
reccamtite	NULL
crersrecer	NULL
eaetcercer	NULL
tecoommace	NULL
rrercactoe	NULL
10GTAMCA	NULL
CroranTCAA	NULL
1682	NULL
sacctosost	NULL
awmertoooa	NULL
cuemasesc	NULL
Thraotasce	NULL
reroascom	NULL
termeacede	NULL
caerrtchch	NULL
cagataaate	NULL
Tetomccas	NULL
Gata	NULL
1533	NULL
a	NULL
183	NULL
teraarcoo	NULL
accacermco	NULL
ca	NULL
a	NULL
Acorarzcan	NULL
caccaccere	NULL
atoracaTeo	NULL
Acaaacceca	NULL
And	NULL
Cr	NULL
C	NULL
a	NULL
ness	NULL
-303	NULL
rercracran	NULL
rTaccreuse	NULL
arectTeraA	NULL
caeaeaarce	NULL
eTromcere	NULL
.	NULL

Ault	NULL
BEP	NULL
26	NULL
caacaorecercrcananaa®	NULL
A	NULL
Ararmaater	NULL
canccacont	NULL
Tor	NULL
oriiceerma	NULL
cccoacartt	NULL
coa	NULL
z	NULL
tytn	NULL
aud	NULL
cos	NULL
exctasmmaptochcator	NULL
auacaocert	NULL
recreaccor	NULL
cnongrerce	NULL
rcarrcroto	NULL
rooropgiga	NULL
aSooch	NULL
cri	NULL
©	NULL
ox	NULL
mas	NULL
cheaterece	NULL
aacteccrta	NULL
arzeccerre	NULL
caoaAco66c	NULL
chaaccatce	NULL
SPT	NULL
R	NULL
a	NULL
a	NULL
a	NULL
;	NULL
saosererer	NULL
arsorcacoe	NULL
aactoorea¢	NULL
roaccacade	NULL
recacastee	NULL
fnsctorcho	NULL
Arcoorc	NULL
@	NULL
mrerCeasctca	NULL
aokmcarice	NULL
accastcore	NULL
rromrerr	NULL
Putative	NULL
regulatory	NULL
motifs	NULL
in	NULL
the	NULL
-2582	NULL
5-flanking	NULL
region	NULL
of	NULL
the	NULL
FecAl	NULL
y	NULL
«	NULL
chain	NULL
gene	NULL
i	NULL
n	NULL
{	NULL
TION	NULL
TGASTMA	NULL
CCMNSSS	NULL
ANATGG	NULL
CTCF	NULL
7	NULL
cecetc	NULL
E2A	NULL
5	NULL
RCAGNTG	NULL
CAAGGTCA	NULL
smaGaway	NULL
WGATAR	NULL
CTGGRAA	NULL
CTKKANNY	NULL
yytecaagar	NULL
|	NULL
(	NULL
ss	NULL
?	NULL

cattoet	NULL
``	NULL
aso	NULL
Grantrkcay	NULL
TKNNGNAAK	NULL
Z	NULL
p	NULL
0	NULL
£	NULL
was	NULL
on	NULL
PEA3	NULL
11	NULL
AGGAAR	NULL
sei	NULL
2	NULL
cceces	NULL
11235	NULL
TGF-	NULL
1	NULL
mamac	NULL
44	NULL
]	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
FceeRI-y	NULL
chain	NULL
gene	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
2,408-base	NULL
pair	NULL
fragment	NULL
spanning	NULL
the	NULL
5	NULL
'	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
FeeRI-y	NULL
chain	NULL
gene	NULL
.	NULL

Position	NULL
1	NULL
corresponds	NULL
to	NULL
the	NULL
start	NULL
codon	NULL
.	NULL

Alu	NULL
repeats	NULL
and	NULL
consensus	NULL
sequences	NULL
for	NULL
GATA	NULL
,	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
CF-1	NULL
,	NULL
cAMP-responsive	NULL
element	NULL
,	NULL
SP-1	NULL
,	NULL
and	NULL
CAAT	NULL
box	NULL
are	NULL
underlined	NULL
.	NULL

The	NULL
stretches	NULL
of	NULL
Alu	NULL
sequences	NULL
are	NULL
typed	NULL
in	NULL
italics	NULL
,	NULL
the	NULL
Lyf-1	NULL
and	NULL
TCF-1	NULL
binding	NULL
sites	NULL
are	NULL
overiined	NULL
,	NULL
and	NULL
the	NULL
putative	NULL
``	NULL
y	NULL
motif	NULL
``	NULL
found	NULL
three	NULL
times	NULL
in	NULL
the	NULL
y	NULL
1357	NULL
negative	NULL
element	NULL
that	NULL
down-regulates	NULL
the	NULL
transcription	NULL
to	NULL
almost	NULL
undetectable	NULL
levels	NULL
;	NULL
that	NULL
the	NULL
sequence	NULL
between	NULL
-1637	NULL
and	NULL
-2382	NULL
confers	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
a	NULL
higher	NULL
level	NULL
in	NULL
basophils	NULL
possibly	NULL
because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
GATA	NULL
site	NULL
found	NULL
at	NULL
-1807	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
promoter	NULL
for	NULL
hematopoietic	NULL
cells	NULL
we	NULL
also	NULL
transfected	NULL
COS-7	NULL
cells	NULL
,	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
and	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
Daudi	NULL
,	NULL
with	NULL
the	NULL
-2382	NULL
construct	NULL
.	NULL

No	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
non-hematopoietic	NULL
COS-7	NULL
cells	NULL
,	NULL
whereas	NULL
a	NULL
basal	NULL
CAT	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
U937	NULL
and	NULL
Daudi	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Promoter	NULL
Confers	NULL
Only	NULL
Partial	NULL
Tissue	NULL
Specificity-Among	NULL
the	NULL
hematopoietic	NULL
cells	NULL
chosen	NULL
for	NULL
transfection	NULL
,	NULL
the	NULL
RBL-2H3	NULL
,	NULL
KUS812	NULL
,	NULL
CEM-CM-3	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
express	NULL
FeeRI-y	NULL
transcripts	NULL
constitutively	NULL
,	NULL
whereas	NULL
Jurkat	NULL
and	NULL
Daudi	NULL
cells	NULL
do	NULL
not	NULL
.	NULL

However	NULL
,	NULL
there	NULL
is	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
transfected	NULL
cells	NULL
according	NULL
to	NULL
whether	NULL
or	NULL
not	NULL
they	NULL
express	NULL
the	NULL
FceeRI-y	NULL
transcripts	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
promoter	NULL
analyzed	NULL
here	NULL
is	NULL
responsible	NULL
for	NULL
only	NULL
part	NULL
of	NULL
the	NULL
tissue	NULL
specificity	NULL
(	NULL
i.e	NULL
.	NULL

hematopoietic	NULL
)	NULL
but	NULL
not	NULL
for	NULL
the	NULL
complete	NULL
specificity	NULL
(	NULL
i.e	NULL
.	NULL

transcription	NULL
in	NULL
-positive	NULL
cells	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
other	NULL
regions	NULL
of	NULL
the	NULL
gene	NULL
may	NULL
control	NULL
the	NULL
specificity	NULL
of	NULL
expression	NULL
in	NULL
FeeRI-y-positive	NULL
cells	NULL
.	NULL

More	NULL
likely	NULL
,	NULL
gene	NULL
methylation	NULL
may	NULL
confer	NULL
that	NULL
specificity	NULL
as	NULL
shown	NULL
for	NULL
the	NULL
gene	NULL
of	NULL
the	NULL
{	NULL
chain	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
,	NULL
a	NULL
gene	NULL
homologous	NULL
to	NULL
the	NULL
y	NULL
gene	NULL
analyzed	NULL
here	NULL
(	NULL
39	NULL
)	NULL
and	NULL
for	NULL
other	NULL
genes	NULL
as	NULL
well	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
nuclear	NULL
factors	NULL
with	NULL
the	NULL
gene	NULL
may	NULL
be	NULL
affected	NULL
by	NULL
different	NULL
DNA	NULL
structures	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
-445/-205	NULL
Fragment	NULL
Contains	NULL
a	NULL
Strongly	NULL
Positive	NULL
,	NULL
Hematopotetic-specific	NULL
Element-The	NULL
most	NULL
significant	NULL
finding	NULL
of	NULL
the	NULL
functional	NULL
analysis	NULL
with	NULL
the	NULL
deletion	NULL
constructs	NULL
is	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
strongly	NULL
positive	NULL
region	NULL
between	NULL
-445	NULL
and	NULL
-295	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

This	NULL
element	NULL
is	NULL
at	NULL
least	NULL
four	NULL
times	NULL
more	NULL
potent	NULL
in	NULL
basophils	NULL
than	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
inactive	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
It	NULL
is	NULL
30	NULL
x	NULL
more	NULL
potent	NULL
in	NULL
RBL	NULL
cells	NULL
than	NULL
the	NULL
SV40	NULL
promoter	NULL
and	NULL
3	NULL
X	NULL
more	NULL
potent	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
is	NULL
active	NULL
in	NULL
many	NULL
other	NULL
hematopoietic	NULL
cells	NULL
including	NULL
U937	NULL
,	NULL
THP1	NULL
,	NULL
and	NULL
HL-60	NULL
,	NULL
NK	NULL
3.3	NULL
,	NULL
murine	NULL
CTLL	NULL
and	NULL
Daudi	NULL
but	NULL
not	NULL
in	NULL
COS-7	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
confirming	NULL
its	NULL
specificity	NULL
to	NULL
cells	NULL
of	NULL
hematopoietic	NULL
lineage	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
to	NULL
what	NULL
is	NULL
observed	NULL
for	NULL
the	NULL
full-length	NULL
construct	NULL
,	NULL
this	NULL
element	NULL
is	NULL
active	NULL
in	NULL
both	NULL
FceRI-y-negative	NULL
and	NULL
FeeRI-y-positive	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
-445/-264	NULL
Fragment	NULL
on	NULL
a	NULL
Heterologous	NULL
Promoter-To	NULL
test	NULL
if	NULL
the	NULL
-445/-264	NULL
region	NULL
could	NULL
also	NULL
up-regulate	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
we	NULL
inserted	NULL
the	NULL
-445/	NULL
-~264	NULL
fragment	NULL
upstream	NULL
or	NULL
downstream	NULL
of	NULL
the	NULL
SV40	NULL
pro-moter-driven	NULL
CAT	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

The	NULL
fragment	NULL
has	NULL
no	NULL
apparent	NULL
effect	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
it	NULL
has	NULL
a	NULL
surprising	NULL
inhibitory	NULL
effect	NULL
in	NULL
transfected	NULL
RBL	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
inhibitory	NULL
effect	NULL
is	NULL
only	NULL
seen	NULL
when	NULL
the	NULL
fragment	NULL
is	NULL
inserted	NULL
5	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
and	NULL
in	NULL
the	NULL
forward	NULL
orientation	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
is	NULL
not	NULL
seen	NULL
when	NULL
the	NULL
insert	NULL
is	NULL
placed	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
binding	NULL
of	NULL
basophil-specific	NULL
nuclear	NULL
factors	NULL
to	NULL
this	NULL
region	NULL
interferes	NULL
nonspecifically	NULL
with	NULL
the	NULL
functioning	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
this	NULL
region	NULL
contains	NULL
a	NULL
basophil-specific	NULL
negative	NULL
element	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
the	NULL
negative	NULL
effect	NULL
of	NULL
this	NULL
fragment	NULL
is	NULL
nullified	NULL
when	NULL
the	NULL
downstream	NULL
sequence	NULL
of	NULL
the	NULL
homologous	NULL
promoter	NULL
is	NULL
present	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
disparate	NULL
effects	NULL
observed	NULL
promoter	NULL
region	NULL
is	NULL
highlighted	NULL
in	NULL
boldface	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
list	NULL
,	NULL
number	NULL
,	NULL
and	NULL
position	NULL
of	NULL
the	NULL
putative	NULL
regulatory	NULL
elements	NULL
corresponding	NULL
to	NULL
the	NULL
consensus	NULL
sequences	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
consensus	NULL
sequences	NULL
are	NULL
listed	NULL
in	NULL
the	NULL
IUPAC-IUB	NULL
code	NULL
(	NULL
38	NULL
)	NULL
.	NULL

1358	NULL
=	NULL
E	NULL
ao	NULL
2	NULL
-	NULL
=	NULL
a	NULL
u	NULL
a	NULL
2	NULL
-=	NULL
=	NULL
f	NULL
A	NULL
$	NULL
3	NULL
o	NULL
i	NULL
60	NULL
i	NULL
i_	NULL
pp	NULL
ca	NULL
_	NULL
u	NULL
3	NULL
d	NULL
1631	NULL
-1296	NULL
``	NULL
445	NULL
126	NULL
CAT	NULL
2382	NULL
1+	NULL
l	NULL
1631	NULL
____	NULL
{	NULL
,	NULL
______._Lm	NULL
1296	NULL
__sp________iSS	NULL
«	NULL
445	NULL
_________usS	NULL
«	NULL
295	NULL
___	NULL
ISS	NULL
237	NULL
_____ISS	NULL
161	NULL
____iSS	NULL
-95	NULL
__iSS	NULL
--	NULL
``	NULL
54	NULL
100	NULL
bp	NULL
_	NULL
1sS	NULL
$	NULL
B	NULL
-	NULL
#	NULL
-	NULL
Hela	NULL
60	NULL
mey	NULL
KUB12	NULL
F	NULL
50	NULL
-	NULL
*~*	NULL
RBL	NULL
€	NULL
it	NULL
:	NULL
40	NULL
a	NULL
4	NULL
2	NULL
i	NULL
*	NULL
‘	NULL
<	NULL
e	NULL
«	NULL
B	NULL
Pee	NULL
€	NULL
A	NULL
1	NULL
a	NULL
*	NULL
®	NULL
£	NULL
2	NULL
y	NULL
'	NULL
b	NULL
«	NULL
L	NULL
U	NULL
K	NULL
\	NULL
**	NULL
Apmis	NULL
wes	NULL
``	NULL
£	NULL
o	NULL
®¥py	NULL
:	NULL
:	NULL
\§	NULL
‘	NULL
.~	NULL
.	NULL

:	NULL
:	NULL
_g	NULL
gig	NULL
!	NULL
}	NULL

~2400	NULL
|	NULL
-2100	NULL
.	NULL

1800	NULL
-	NULL
+1500	NULL
-	NULL
1200	NULL
900	NULL
~500	NULL
~300	NULL
g	NULL
C	NULL
20	NULL
-	NULL
@	NULL
~~	NULL
Hela	NULL
18	NULL
=	NULL
*~	NULL
CEM-CM-3	NULL
£16	NULL
=m	NULL
*	NULL
Jurkat	NULL
E14	NULL
412	NULL
+	NULL
<	NULL
#	NULL
``	NULL
B	NULL
»	NULL
``	NULL
4	NULL
>	NULL
a	NULL
is	NULL
-	NULL
+	NULL
‘	NULL
$	NULL
e	NULL
-	NULL
``	NULL
U	NULL
Cos	NULL
a*	NULL
j-~	NULL
A	NULL
PP	NULL
0	NULL
a	NULL
``	NULL
~	NULL
vj	NULL
-L	NULL
~	NULL
:	NULL
|	NULL
oe	NULL
``	NULL
bese	NULL
LHV-	NULL
‘	NULL
nu	NULL
L	NULL
'	NULL
.	NULL
``	NULL

1-4	NULL
a	NULL
[	NULL
--	NULL
w	NULL
-a	NULL
ta	NULL
+2400	NULL
-	NULL
-2100	NULL
-	NULL
-1800	NULL
-	NULL
1500	NULL
_	NULL
1200	NULL
900	NULL
-600	NULL
-300	NULL
0	NULL
Nucleotides	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
y	NULL
chain	NULL
gene	NULL
by	NULL
CAT	NULL
assay	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
human	NULL
FceRI-y	NULL
gene	NULL
chimeric	NULL
CAT	NULL
plasmids	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
CAT	NULL
activities	NULL
of	NULL
the	NULL
various	NULL
deletions	NULL
constructs	NULL
transfected	NULL
into	NULL
human	NULL
(	NULL
KUS12	NULL
cells	NULL
)	NULL
and	NULL
rat	NULL
(	NULL
RBL-2H3	NULL
cells	NULL
)	NULL
basophils	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
detected	NULL
in	NULL
HeLa	NULL
cell	NULL
lysates	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

Panel	NULL
C	NULL
,	NULL
CAT	NULL
activities	NULL
in	NULL
transfected	NULL
human	NULL
T	NULL
lymphocyte	NULL
cell	NULL
lines	NULL
(	NULL
CEM-CM-3	NULL
and	NULL
Jurkat	NULL
)	NULL
and	NULL
in	NULL
HeLa	NULL
celis	NULL
.	NULL

The	NULL
relative	NULL
CAT	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
percent	NULL
of	NULL
conversion	NULL
of	NULL
the	NULL
chloramphenicol	NULL
to	NULL
its	NULL
acetylated	NULL
forms	NULL
.	NULL

The	NULL
graphics	NULL
represent	NULL
the	NULL
averages	NULL
of	NULL
the	NULL
relative	NULL
CAT	NULL
activity	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
at	NULL
least	NULL
five	NULL
separate	NULL
transfections	NULL
for	NULL
each	NULL
construct	NULL
and	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
done	NULL
in	NULL
duplicate	NULL
.	NULL

The	NULL
CAT	NULL
activities	NULL
have	NULL
been	NULL
standardized	NULL
by	NULL
using	NULL
units	NULL
of	NULL
the	NULL
B-galactosidase	NULL
activity	NULL
resulting	NULL
from	NULL
the	NULL
cotransfection	NULL
of	NULL
the	NULL
pCMV-	NULL
#	NULL
-galactosidase	NULL
plasmid	NULL
.	NULL

in	NULL
T	NULL
cells	NULL
and	NULL
basophils	NULL
support	NULL
our	NULL
contention	NULL
that	NULL
the	NULL
nuclear	NULL
factors	NULL
interacting	NULL
with	NULL
this	NULL
region	NULL
are	NULL
different	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
basophils	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
-445/-264	NULL
Fragment	NULL
Binds	NULL
to	NULL
Specific	NULL
Nuclear	NULL
Fac-tors-We	NULL
analyzed	NULL
by	NULL
EMSA	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
HindIII/	NULL
Accl	NULL
fragment	NULL
(	NULL
-445/-264	NULL
)	NULL
to	NULL
bind	NULL
to	NULL
specific	NULL
nuclear	NULL
factors	NULL
extracted	NULL
from	NULL
the	NULL
cells	NULL
used	NULL
in	NULL
the	NULL
functional	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
extracted	NULL
from	NULL
Jurkat	NULL
,	NULL
CEM-CM-3	NULL
,	NULL
and	NULL
RBL	NULL
cells	NULL
bind	NULL
to	NULL
this	NULL
fragment	NULL
.	NULL

This	NULL
binding	NULL
is	NULL
blocked	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
FeeRI-	NULL
»	NULL
y	NULL
Chain	NULL
Gene	NULL
A	NULL
psvao-cat	NULL
mp	NULL
]	NULL
car	NULL
|	NULL
}	NULL
=	NULL
svao	NULL
promoten	NULL
alte	NULL
\-	NULL
``	NULL
'	NULL
,	NULL
Syed	NULL
pRoMOTER	NULL
-	NULL
svao	NULL
PRomMoteR	NULL
.	NULL

445	NULL
0-264	NULL
445	NULL
-	NULL
``	NULL
264	NULL
Hind	NULL
Itt	NULL
_	NULL
Ace	NULL
!	NULL

Hind	NULL
11	NULL
__	NULL
Ace	NULL
!	NULL

.	NULL

Bgl	NULL
1+445/-264	NULL
pSV40-CAT	NULL
»	NULL
pSV40-	NULL
CAT	NULL
BamH	NULL
[	NULL
~445/-264	NULL
0.5	NULL
Relative	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
0.0	NULL
RBL-2H3	NULL
Jurkat	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
transcriptionally	NULL
active	NULL
human	NULL
y	NULL
sequences	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
SV40	NULL
early	NULL
promoter-CAT	NULL
constructs	NULL
made	NULL
to	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
-445/-264	NULL
y	NULL
region	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

The	NULL
control	NULL
plasmid	NULL
is	NULL
the	NULL
vector	NULL
pSV40-CAT	NULL
(	NULL
§	NULL
)	NULL
.	NULL

The	NULL
-445/-264	NULL
human	NULL
y	NULL
fragment	NULL
was	NULL
inserted	NULL
5¢	NULL
(	NULL
)	NULL
or	NULL
3	NULL
``	NULL
(	NULL
C	NULL
]	NULL
)	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
functional	NULL
analysis	NULL
of	NULL
SV40	NULL
promoter	NULL
constructs	NULL
transiently	NULL
transfected	NULL
in	NULL
RBL-2H3	NULL
cells	NULL
or	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
bars	NULL
represent	NULL
the	NULL
average	NULL
percent	NULL
of	NULL
conversion	NULL
of	NULL
CAT	NULL
to	NULL
its	NULL
acetylated	NULL
products	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
separate	NULL
transfections	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

efficiently	NULL
by	NULL
using	NULL
unlabeled	NULL
-445/-180	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
9	NULL
,	NULL
and	NULL
14	NULL
)	NULL
or	NULL
~366/-290	NULL
fragments	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
15	NULL
)	NULL
but	NULL
not	NULL
by	NULL
unrelated	NULL
ones	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
and	NULL
13	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
nuclear	NULL
factors	NULL
binding	NULL
specifically	NULL
to	NULL
the	NULL
-445/-264	NULL
region	NULL
are	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
different	NULL
patterns	NULL
obtained	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
RBL	NULL
cells	NULL
and	NULL
from	NULL
Jurkat	NULL
or	NULL
CEM-CM-3	NULL
cells	NULL
suggest	NULL
that	NULL
the	NULL
factors	NULL
binding	NULL
this	NULL
region	NULL
are	NULL
different	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
basophils	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
binding	NULL
capacity	NULL
of	NULL
the	NULL
-445/-180	NULL
fragment	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
no	NULL
specific	NULL
binding	NULL
with	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
HeLa	NULL
cells	NULL
but	NULL
found	NULL
virtually	NULL
the	NULL
same	NULL
patterns	NULL
of	NULL
retarded	NULL
bands	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
,	NULL
CEM-CM-3	NULL
,	NULL
and	NULL
RBL	NULL
cells	NULL
as	NULL
those	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
-264/-180	NULL
region	NULL
does	NULL
not	NULL
participate	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
specific	NULL
nuclear	NULL
factors	NULL
.	NULL

The	NULL
-366/-290	NULL
Region	NULL
Binds	NULL
to	NULL
Nuclear	NULL
Factors	NULL
That	NULL
Are	NULL
Different	NULL
in	NULL
Basophils	NULL
and	NULL
T	NULL
Cells-Since	NULL
the	NULL
~366/-290	NULL
fragment	NULL
is	NULL
an	NULL
efficient	NULL
inhibitor	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
-445/-264	NULL
region	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
use	NULL
the	NULL
radiolabeled	NULL
-366/-290	NULL
fragment	NULL
itself	NULL
in	NULL
binding	NULL
studies	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
patterns	NULL
of	NULL
retarded	NULL
bands	NULL
are	NULL
different	NULL
when	NULL
the	NULL
binding	NULL
is	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
or	NULL
of	NULL
poly	NULL
(	NULL
dG-dC	NULL
)	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
conditions	NULL
,	NULL
the	NULL
patterns	NULL
of	NULL
retarded	NULL
bands	NULL
are	NULL
also	NULL
different	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Jurkat	NULL
and	NULL
CEM-CM-3	NULL
)	NULL
and	NULL
basophils	NULL
(	NULL
RBL-2H3	NULL
and	NULL
KUS812	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
those	NULL
obtained	NULL
with	NULL
the	NULL
larger	NULL
-445/-264	NULL
fragment	NULL
,	NULL
suggesting	NULL
once	NULL
again	NULL
that	NULL
the	NULL
nuclear	NULL
factors	NULL
interacting	NULL
with	NULL
this	NULL
region	NULL
are	NULL
different	NULL
in	NULL
basophils	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
subsequently	NULL
studied	NULL
the	NULL
capacity	NULL
of	NULL
short	NULL
,	NULL
double	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
FeeRI-	NULL
»	NULL
y	NULL
Chain	NULL
Gene	NULL
A	NULL
Hind	NULL
III	NULL
Bgi1	NULL
-	NULL
Acc	NULL
1	NULL
Bgl	NULL
II	NULL
+1	NULL
‘	NULL
1	NULL
|	NULL
ft	NULL
T	NULL
T	NULL
+366	NULL
-290	NULL
-54	NULL
+26	NULL
-445/-180	NULL
-445/264	NULL
-445/-365	NULL
-366/-290	NULL
-54/426	NULL
B	NULL
EXTRACTS	NULL
:	NULL
_	NULL
none	NULL
_	NULL
Jurkat	NULL
CEM-CM-3	NULL
RBL	NULL
-2H3	NULL
£8	NULL
ge	NULL
00	NULL
$	NULL
5§fe	NULL
0	NULL
45	NULL
$	NULL
Competitor	NULL
:	NULL
_i§§§	NULL
_i§§§	NULL
—i£§	NULL
wth	NULL
nt	NULL
,	NULL
,	NULL
bian	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
607	NULL
8	NULL
9	NULL
1011	NULL
121314	NULL
15	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
(	NULL
-445/-264	NULL
)	NULL
fragment	NULL
of	NULL
the	NULL
FceRI-y	NULL
chain	NULL
gene	NULL
.	NULL

Analysis	NULL
was	NULL
by	NULL
EMSA	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
probes	NULL
and	NULL
DNA	NULL
fragments	NULL
used	NULL
in	NULL
EMSAs	NULL
.	NULL

The	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
shows	NULL
a	NULL
partial	NULL
restriction	NULL
map	NULL
of	NULL
the	NULL
region	NULL
between	NULL
~445	NULL
and	NULL
+26	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
EMSA	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
2-6	NULL
)	NULL
,	NULL
CEM-CM-3	NULL
cells	NULL
(	NULL
lanes	NULL
7-11	NULL
)	NULL
,	NULL
and	NULL
RBL-2H3	NULL
cells	NULL
(	NULL
lanes	NULL
12-15	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
P-labeled	NULL
-445/-264	NULL
fragment	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
poly	NULL
(	NULL
dI	NULL
-	NULL
dC	NULL
)	NULL
as	NULL
nonspecific	NULL
competitor	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
the	NULL
labeled	NULL
probe	NULL
alone	NULL
.	NULL

Unlabeled	NULL
DNA	NULL
fragments	NULL
used	NULL
as	NULL
competitors	NULL
are	NULL
indicated	NULL
.	NULL

stranded	NULL
oligonucleotides	NULL
to	NULL
inhibit	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
-366/-290	NULL
element	NULL
in	NULL
RBL-2H3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
and	NULL
in	NULL
CEM-CM-3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Two	NULL
major	NULL
bands	NULL
in	NULL
RBL	NULL
cells	NULL
and	NULL
one	NULL
major	NULL
band	NULL
in	NULL
CEM-CM-3	NULL
cells	NULL
are	NULL
detected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
unlabeled	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
(	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
and	NULL
are	NULL
therefore	NULL
considered	NULL
to	NULL
be	NULL
specific	NULL
.	NULL

These	NULL
bands	NULL
are	NULL
not	NULL
observed	NULL
following	NULL
competition	NULL
with	NULL
the	NULL
homologous	NULL
cold	NULL
fragment	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
but	NULL
are	NULL
observed	NULL
following	NULL
competition	NULL
with	NULL
the	NULL
-384/-365	NULL
oligonucleotide	NULL
,	NULL
whose	NULL
sequence	NULL
is	NULL
located	NULL
5	NULL
of	NULL
the	NULL
relevant	NULL
sequence	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
-364/-345	NULL
oligonucleotide	NULL
is	NULL
inhibitory	NULL
in	NULL
RBL	NULL
cells	NULL
and	NULL
may	NULL
have	NULL
a	NULL
slight	NULL
inhibitory	NULL
effect	NULL
in	NULL
CEM-CM-3	NULL
cells	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Since	NULL
a	NULL
Lyf-1	NULL
motif	NULL
is	NULL
present	NULL
in	NULL
the	NULL
-364/-345	NULL
region	NULL
,	NULL
Lyf-binding	NULL
factors	NULL
already	NULL
known	NULL
to	NULL
be	NULL
present	NULL
in	NULL
various	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
could	NULL
potentially	NULL
explain	NULL
the	NULL
hematopoietic	NULL
specificity	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
the	NULL
surprising	NULL
finding	NULL
that	NULL
the	NULL
-284/-260	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
and	NULL
-50/+26	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
oligonucleotides	NULL
also	NULL
inhibit	NULL
binding	NULL
in	NULL
RBL	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
CEM-CM-3	NULL
cells	NULL
led	NULL
us	NULL
to	NULL
speculate	NULL
that	NULL
a	NULL
sequence	NULL
other	NULL
than	NULL
the	NULL
Lyf-1	NULL
motif	NULL
might	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
binding	NULL
.	NULL

Indeed	NULL
,	NULL
sequence	NULL
comparison	NULL
between	NULL
these	NULL
two	NULL
oligonucleotides	NULL
and	NULL
the	NULL
-366/-290	NULL
element	NULL
reveals	NULL
a	NULL
common	NULL
motif	NULL
if	NULL
one	NULL
allows	NULL
for	NULL
two	NULL
mismatches	NULL
.	NULL

This	NULL
motif	NULL
is	NULL
not	NULL
found	NULL
anywhere	NULL
else	NULL
in	NULL
the	NULL
2.4	NULL
kilobases	NULL
of	NULL
the	NULL
5	NULL
'	NULL
region	NULL
.	NULL

The	NULL
sequence	NULL
GCACTCCAGC	NULL
is	NULL
found	NULL
at	NULL
-355	NULL
right	NULL
after	NULL
the	NULL
Lyf-1	NULL
motif	NULL
,	NULL
the	NULL
sequence	NULL
GatCTCCAGC	NULL
is	NULL
found	NULL
at	NULL
-15	NULL
,	NULL
and	NULL
the	NULL
complementary	NULL
sequence	NULL
to	NULL
cCACTCCAcC	NULL
is	NULL
found	NULL
at	NULL
-277	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
common	NULL
motif	NULL
explains	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
-284/	NULL
-260	NULL
and	NULL
-50/+26	NULL
oligonucleotides	NULL
in	NULL
RBL	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
also	NULL
1359	NULL
A	NULL
&	NULL
Extracts	NULL
:	NULL
£	NULL
al	NULL
:	NULL
ac	NULL
dG	NULL
:	NULL
aC	NULL
mo	NULL
bck	NULL
boss	NULL
an	NULL
%	NULL
>	NULL
wn	NULL
gg	NULL
an	NULL
«	NULL
=	NULL
--	NULL
a-	NULL
an	NULL
as	NULL
an	NULL
swig	NULL
B	NULL
|	NULL
,	NULL
@	NULL
H	NULL
RBL-2H3	NULL
nuclear	NULL
extract	NULL
B	NULL
8	NULL
a	NULL
n	NULL
©	NULL
g	NULL
won	NULL
0	NULL
§§	NULL
5	NULL
5	NULL
§	NULL
5	NULL
§	NULL
#	NULL
ig	NULL
;	NULL
Competitor	NULL
:	NULL
iiiﬁgggg	NULL
‘	NULL
i-ﬁ	NULL
}	NULL
tl	NULL
C	NULL
&	NULL
-	NULL
>	NULL
-	NULL
>	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
607	NULL
8	NULL
g	NULL
10	NULL
11	NULL
293	NULL
CEM-CM-3	NULL
nuclear	NULL
extract	NULL
C	NULL
#	NULL
g	NULL
g	NULL
s	NULL
&	NULL
$	NULL
§	NULL
§	NULL
&	NULL
&	NULL
&	NULL
8	NULL
is	NULL
.-Competitor	NULL
:	NULL
I	NULL
*S*	NULL
$	NULL
\'\	NULL
'	NULL
5B	NULL
[	NULL
@	NULL
oo	NULL
t	NULL
-	NULL
h	NULL
&	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
1213	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Binding	NULL
of	NULL
specific	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
-366/	NULL
-290	NULL
fragment	NULL
of	NULL
the	NULL
FceRI-y	NULL
gene	NULL
promoter	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
EMSA	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
,	NULL
CEM-CM-3	NULL
,	NULL
HeLa	NULL
,	NULL
RBL-2H3	NULL
,	NULL
and	NULL
KU812	NULL
cell	NULL
lines	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
P-labeled	NULL
-366/-290	NULL
fragment	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
or	NULL
poly	NULL
(	NULL
dG-dC	NULL
)	NULL
as	NULL
nonspecific	NULL
competitor	NULL
.	NULL

Panels	NULL
B	NULL
and	NULL
C	NULL
,	NULL
EMSA	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
RBL-2H3	NULL
and	NULL
CEM-CM-3	NULL
cell	NULL
lines	NULL
as	NULL
in	NULL
panel	NULL
A	NULL
and	NULL
with	NULL
the	NULL
poly	NULL
(	NULL
dG-dC	NULL
)	NULL
as	NULL
nonspecific	NULL
inhibitor	NULL
.	NULL

DNA	NULL
fragments	NULL
used	NULL
as	NULL
competitors	NULL
are	NULL
indicated	NULL
.	NULL

tempting	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
same	NULL
basophil-specific	NULL
factors	NULL
interact	NULL
with	NULL
these	NULL
three	NULL
motifs	NULL
.	NULL

This	NULL
could	NULL
explain	NULL
why	NULL
the	NULL
-445/-264	NULL
fragment	NULL
has	NULL
a	NULL
different	NULL
activity	NULL
when	NULL
placed	NULL
in	NULL
front	NULL
of	NULL
a	NULL
heterologous	NULL
promoter	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

Obviously	NULL
,	NULL
further	NULL
characterization	NULL
of	NULL
the	NULL
motif	NULL
and	NULL
of	NULL
possible	NULL
binding	NULL
factors	NULL
needs	NULL
to	NULL
be	NULL
done	NULL
.	NULL

Detection	NULL
of	NULL
Two	NULL
Adjacent	NULL
Regulatory	NULL
Elements	NULL
in	NULL
the	NULL
-445/	NULL
-264	NULL
Region-To	NULL
analyze	NULL
further	NULL
the	NULL
differential	NULL
function	NULL
of	NULL
the	NULL
-445/-264	NULL
fragment	NULL
in	NULL
basophils	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
studied	NULL
additional	NULL
deletion	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Removing	NULL
the	NULL
region	NULL
between	NULL
-365	NULL
and	NULL
-264	NULL
results	NULL
in	NULL
an	NULL
89	NULL
%	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
in	NULL
basophils	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
complete	NULL
-445/	NULL
+26	NULL
region	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
significant	NULL
difference	NULL
is	NULL
detected	NULL
1360	NULL
A	NULL
B	NULL
human	NULL
y	NULL
gene	NULL
445-365	NULL
-264	NULL
-	NULL
41	NULL
--	NULL
-+26	NULL
CAT	NULL
445	NULL
___	NULL
_	NULL
iss	NULL
-445	NULL
gap	NULL
(	NULL
365-264	NULL
)	NULL
VJ	NULL
-365	NULL
___	NULL
___iSSY	NULL
80	NULL
0	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
FeeRI-y	NULL
Chain	NULL
Gene	NULL
so	NULL
100	NULL
180	NULL
200	NULL
280-50	NULL
0	NULL
o	NULL
0	NULL
so	NULL
.	NULL

100	NULL
Arbitrary	NULL
unite	NULL
Arbitrary	NULL
unite	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
-445/-264	NULL
region	NULL
:	NULL
detection	NULL
of	NULL
two	NULL
adjacent	NULL
regulatory	NULL
elements	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
human	NULL
FeeRI-y	NULL
gene	NULL
CAT	NULL
constructs	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
CAT	NULL
activities	NULL
in	NULL
transfected	NULL
RBL	NULL
-2H3	NULL
and	NULL
in	NULL
CEM-CM-3	NULL
cells	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
analyzed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
transfection	NULL
for	NULL
each	NULL
construct	NULL
.	NULL

The	NULL
data	NULL
have	NULL
been	NULL
normalized	NULL
as	NULL
follows	NULL
.	NULL

The	NULL
activities	NULL
corresponding	NULL
to	NULL
the	NULL
-2382	NULL
and	NULL
to	NULL
the	NULL
-445	NULL
CAT	NULL
construct	NULL
were	NULL
considered	NULL
as	NULL
1	NULL
and	NULL
100	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

are	NULL
shown	NULL
for	NULL
each	NULL
construct	NULL
.	NULL

The	NULL
differences	NULL
of	NULL
CAT	NULL
activity	NULL
between	NULL
the	NULL
-445	NULL
and	NULL
the	NULL
-445	NULL
gap	NULL
(	NULL
-365/-264	NULL
)	NULL
CAT	NULL
on	NULL
the	NULL
one	NULL
hand	NULL
,	NULL
and	NULL
between	NULL
the	NULL
-445	NULL
and	NULL
-366	NULL
CAT	NULL
constructs	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
are	NULL
both	NULL
highly	NULL
significant	NULL
in	NULL
RBL-2H3	NULL
cells	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

II	NULL
GGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGA	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
-§33	NULL
-523	NULL
~513	NULL
-503	NULL
~493	NULL
~483	NULL
I	NULL
TCACCTGAGATCAGGAGTTCAAGACCAGCCTGATCAACATGGAGAAACCCCATCTCTACT	NULL
A	NULL
FPﬁPTFTCTACT	NULL
110	NULL
120	NULL
~473	NULL
-463	NULL
~453	NULL
~423	NULL
I	NULL
-	NULL
AAAAATAC-AAAATTAGCTGSGCGTGG	NULL
:	NULL
II	NULL
AAAAATACAAAAATTAGCCGGGCGTGGTGGCGCGCGCCTGTAGTCCCAGCTACTCGGGAG	NULL
130	NULL
140	NULL
150	NULL
160	NULL
170	NULL
180	NULL
-373	NULL
-363	NULL
II	NULL
GCTGaSec	NULL
TCGCTTGAACC	NULL
TTGCAGT	NULL
CCGAGATCGCG	NULL
190	NULL
200	NULL
210	NULL
220	NULL
230	NULL
240	NULL
-353	NULL
~343	NULL
~333	NULL
-323	NULL
~313	NULL
-303	NULL
I	NULL
II	NULL
CCACTGCACTCCAGCCTGGGCGACAGAGCGAGACTCCGTC	NULL
250	NULL
260	NULL
270	NULL
280	NULL
FiG	NULL
.	NULL

7	NULL
.	NULL

Alignment	NULL
of	NULL
the	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
(	NULL
2	NULL
)	NULL
with	NULL
the	NULL
primate-specific	NULL
Alu	NULL
consensus	NULL
sequence	NULL
(	NULL
IF	NULL
)	NULL
.	NULL

The	NULL
adjacent	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
y	NULL
chain	NULL
gene	NULL
are	NULL
underlined	NULL
.	NULL

The	NULL
consensus	NULL
Alu	NULL
sequence	NULL
corresponds	NULL
to	NULL
the	NULL
primate-specific	NULL
Alu	NULL
consensus	NULL
sequence	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
stretch	NULL
of	NULL
consecutive	NULL
adenines	NULL
is	NULL
typical	NULL
of	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
Alu	NULL
sequences	NULL
,	NULL
although	NULL
the	NULL
number	NULL
of	NULL
these	NULL
adenines	NULL
is	NULL
variable	NULL
.	NULL

Here	NULL
only	NULL
18	NULL
out	NULL
of	NULL
the	NULL
23	NULL
adenines	NULL
found	NULL
in	NULL
the	NULL
y	NULL
chain	NULL
gene	NULL
are	NULL
shown	NULL
.	NULL

Double	NULL
dots	NULL
indicate	NULL
identical	NULL
nucleotides	NULL
,	NULL
and	NULL
dashes	NULL
correspond	NULL
to	NULL
gaps	NULL
or	NULL
deletions	NULL
.	NULL

in	NULL
T	NULL
cells	NULL
.	NULL

Therefore	NULL
the	NULL
-365/-264	NULL
element	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
in	NULL
basophils	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
-445/-366	NULL
region	NULL
abolishes	NULL
the	NULL
CAT	NULL
activity	NULL
in	NULL
RBL	NULL
cells	NULL
but	NULL
yield	NULL
only	NULL
a	NULL
40	NULL
%	NULL
reduction	NULL
in	NULL
CEM-CM-3	NULL
cells	NULL
.	NULL

Indeed	NULL
in	NULL
CEM-CM-8	NULL
cells	NULL
,	NULL
a	NULL
further	NULL
deletion	NULL
of	NULL
the	NULL
~-365/-295	NULL
region	NULL
is	NULL
required	NULL
to	NULL
reduce	NULL
the	NULL
CAT	NULL
activity	NULL
to	NULL
basal	NULL
level	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
-445/	NULL
-366	NULL
element	NULL
is	NULL
a	NULL
positive	NULL
element	NULL
in	NULL
both	NULL
basophils	NULL
and	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
-365/-264	NULL
element	NULL
contains	NULL
an	NULL
activator	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
basophils	NULL
.	NULL

The	NULL
Two	NULL
cis-	NULL
Acting	NULL
Regulatory	NULL
Elements	NULL
Are	NULL
Part	NULL
of	NULL
an	NULL
Alu	NULL
Repeat-As	NULL
mentioned	NULL
above	NULL
,	NULL
the	NULL
5	NULL
sequence	NULL
of	NULL
the	NULL
y	NULL
chain	NULL
gene	NULL
contains	NULL
two	NULL
typical	NULL
Alu	NULL
repeats	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
sequence	NULL
containing	NULL
the	NULL
two	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
(	NULL
~445/-366	NULL
and	NULL
-365/-264	NULL
elements	NULL
)	NULL
with	NULL
Alu	NULL
consensus	NULL
sequences	NULL
shows	NULL
that	NULL
the	NULL
regulatory	NULL
elements	NULL
are	NULL
within	NULL
the	NULL
sequence	NULL
of	NULL
Alu	NULL
repeats	NULL
.	NULL

Among	NULL
all	NULL
subfamilies	NULL
of	NULL
Alu	NULL
sequences	NULL
(	NULL
41	NULL
)	NULL
,	NULL
the	NULL
best	NULL
alignment	NULL
was	NULL
with	NULL
the	NULL
primate-specific	NULL
Alu	NULL
consensus	NULL
sequence	NULL
.	NULL

We	NULL
found	NULL
that	NULL
about	NULL
90	NULL
%	NULL
of	NULL
the	NULL
nucleotides	NULL
are	NULL
identical	NULL
between	NULL
the	NULL
two	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

There	NULL
are	NULL
examples	NULL
of	NULL
Alu	NULL
sequences	NULL
containing	NULL
negative	NULL
regulatory	NULL
elements	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
,	NULL
but	NULL
we	NULL
are	NULL
not	NULL
aware	NULL
of	NULL
any	NULL
example	NULL
of	NULL
positive	NULL
regulatory	NULL
elements	NULL
containing	NULL
Alu	NULL
se-quences	NULL
.	NULL

Clearly	NULL
the	NULL
entire	NULL
(	NULL
-445/-366	NULL
)	NULL
-positive	NULL
element	NULL
is	NULL
part	NULL
of	NULL
the	NULL
Alu	NULL
repeat	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
other	NULL
element	NULL
(	NULL
-365/	NULL
-264	NULL
)	NULL
overlaps	NULL
also	NULL
with	NULL
the	NULL
Alu	NULL
consensus	NULL
sequence	NULL
,	NULL
but	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
that	NULL
the	NULL
sequence	NULL
from	NULL
-296	NULL
to	NULL
-264	NULL
,	NULL
which	NULL
is	NULL
not	NULL
part	NULL
of	NULL
the	NULL
Alu	NULL
repeat	NULL
,	NULL
is	NULL
critical	NULL
for	NULL
its	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
our	NULL
binding	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
active	NULL
region	NULL
of	NULL
the	NULL
(	NULL
-365/-264	NULL
)	NULL
element	NULL
is	NULL
between	NULL
-365	NULL
and	NULL
-290	NULL
and	NULL
is	NULL
within	NULL
the	NULL
Alu	NULL
repeat	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
FceRI-y	NULL
chain	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
positive	NULL
and	NULL
negative	NULL
cis-acting	NULL
elements	NULL
.	NULL

These	NULL
elements	NULL
are	NULL
part	NULL
of	NULL
an	NULL
Alu	NULL
repeat	NULL
,	NULL
are	NULL
only	NULL
active	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
and	NULL
are	NULL
recognized	NULL
by	NULL
DNA-binding	NULL
proteins	NULL
in	NULL
a	NULL
cell	NULL
type-specific	NULL
manner	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1990	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

2	NULL
,	NULL
499-505	NULL
2	NULL
.	NULL

Ravetch	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1991	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9	NULL
,	NULL
457-492	NULL
3	NULL
.	NULL

Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

4	NULL
,	NULL
43-48	NULL
4	NULL
.	NULL

Blank	NULL
,	NULL
U.	NULL
,	NULL
Ra	NULL
,	NULL
C.	NULL
,	NULL
Miller	NULL
,	NULL
L.	NULL
,	NULL
White	NULL
,	NULL
K.	NULL
,	NULL
Metzger	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
387	NULL
,	NULL
187-189	NULL
5	NULL
.	NULL

Wang	NULL
,	NULL
B.	NULL
,	NULL
Rieger	NULL
,	NULL
A.	NULL
,	NULL
Kilgus	NULL
,	NULL
O.	NULL
,	NULL
Ochiai	NULL
,	NULL
K.	NULL
,	NULL
Maurer	NULL
,	NULL
D.	NULL
,	NULL
Fodinger	NULL
,	NULL
D.	NULL
,	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
,	NULL
and	NULL
Stingl	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1353-1365	NULL
6	NULL
.	NULL

Bieber	NULL
,	NULL
T.	NULL
,	NULL
de	NULL
la	NULL
Salle	NULL
,	NULL
H.	NULL
,	NULL
Wollenberg	NULL
,	NULL
A.	NULL
,	NULL
Hakimi	NULL
,	NULL
J.	NULL
,	NULL
Chizzonite	NULL
,	NULL
R.	NULL
,	NULL
Ring	NULL
,	NULL
J.	NULL
,	NULL
Hanau	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
de	NULL
la	NULL
Salle	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1285-1290	NULL
7	NULL
.	NULL

Ra	NULL
,	NULL
C	NULL
Jouvin	NULL
,	NULL
M	NULL
H.	NULL
E.	NULL
,	NULL
Blank	NULL
U.	NULL
,	NULL
and	NULL
Kinet	NULL
J.-P.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
341	NULL
,	NULL
752—7	NULL
4	NULL
8	NULL
.	NULL

Orloff	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Ra	NULL
,	NULL
C.	NULL
,	NULL
Frank	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
F.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
347	NULL
,	NULL
189—191	NULL
9	NULL
.	NULL

Vivier	NULL
,	NULL
E.	NULL
,	NULL
Rochet	NULL
,	NULL
N.	NULL
,	NULL
Kochan	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Presky	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Schlossman	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
and	NULL
Anderson	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
4263-4270	NULL
.	NULL

Koyasu	NULL
,	NULL
S.	NULL
,	NULL
D'Adamio	NULL
,	NULL
D.	NULL
,	NULL
Arulanandam	NULL
,	NULL
A.	NULL
R.	NULL
N.	NULL
,	NULL
Abraham	NULL
,	NULL
S.	NULL
,	NULL
Clayton	NULL
,	NULL
.	NULL

K.	NULL
,	NULL
and	NULL
Reinherz	NULL
,	NULL
E.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
203-209	NULL
.	NULL

Hibbs	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Selvaraj	NULL
,	NULL
P.	NULL
,	NULL
Carpen	NULL
,	NULL
O.	NULL
,	NULL
Springer	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Kiister	NULL
,	NULL
H.	NULL
,	NULL
Jouvin	NULL
,	NULL
M.	NULL
H.	NULL
E.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
1608-1611	NULL
.	NULL

Kurosaki	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ravetch	NULL
,	NULL
J.	NULL
V.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
842	NULL
,	NULL
805-807	NULL
.	NULL

Lanier	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Yu	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Phillips	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
342	NULL
,	NULL
803-804	NULL
.	NULL

Anderson	NULL
,	NULL
P.	NULL
,	NULL
Caligiuri	NULL
,	NULL
M.	NULL
,	NULL
O'Brien	NULL
,	NULL
C.	NULL
,	NULL
Manley	NULL
,	NULL
T.	NULL
,	NULL
Ritz	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Schlossman	NULL
,	NULL
S.	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
.	NULL

S	NULL
,	NULL
A	NULL
.	NULL

87	NULL
,	NULL
2274-2278	NULL
.	NULL

Letourneur	NULL
,	NULL
O.	NULL
,	NULL
Kennedy	NULL
,	NULL
I.	NULL
C.	NULL
S.	NULL
,	NULL
Brini	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
2652-2656	NULL
.	NULL

Kiister	NULL
,	NULL
H.	NULL
,	NULL
Thompson	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
6448-6452	NULL
.	NULL

Weissman	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Baniyash	NULL
,	NULL
M.	NULL
,	NULL
Hou	NULL
,	NULL
D.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Burgess	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
and	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
239	NULL
,	NULL
1018-1021	NULL
.	NULL

Weissman	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Hou	NULL
,	NULL
D.	NULL
,	NULL
Orloff	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Modi	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Seuanez	NULL
,	NULL
H.	NULL
,	NULL
O'Brien	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
.	NULL

8	NULL
.	NULL

A	NULL
.	NULL

85	NULL
,	NULL
9709-9713	NULL
19	NULL
.	NULL

Baniyash	NULL
,	NULL
M.	NULL
,	NULL
Hsu	NULL
,	NULL
V.	NULL
W.	NULL
,	NULL
Seldin	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
13252-13257	NULL
20	NULL
.	NULL

Jin	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
Clayton	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
Howard	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
Koyasu	NULL
,	NULL
S.	NULL
,	NULL
Sieh	NULL
,	NULL
M.	NULL
,	NULL
Steinbrich	NULL
,	NULL
R.	NULL
,	NULL
Tarr	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
Reinherz	NULL
,	NULL
E.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
3319-3323	NULL
21	NULL
.	NULL

Huppi	NULL
,	NULL
K.	NULL
,	NULL
Siwarski	NULL
,	NULL
D.	NULL
,	NULL
Mock	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

143	NULL
,	NULL
3787-3791	NULL
22	NULL
.	NULL

Letourneur	NULL
,	NULL
F.	NULL
,	NULL
Mattei	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
Malissen	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Immunogenetics	NULL
29	NULL
,	NULL
265-268	NULL
23	NULL
.	NULL

Le	NULL
Coniat	NULL
,	NULL
M.	NULL
,	NULL
Kinet	NULL
,	NULL
J.-P.	NULL
,	NULL
and	NULL
Berger	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Immunogenetics	NULL
32	NULL
,	NULL
183-186	NULL
24	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
25	NULL
.	NULL

Kishi	NULL
,	NULL
K.	NULL
(	NULL
1985	NULL
)	NULL
Leuk	NULL
.	NULL

Res	NULL
.	NULL

9	NULL
,	NULL
381-390	NULL
Ho	NULL
ge	NULL
ob	NULL
bid	NULL
Hobs	NULL
s	NULL
&	NULL
on	NULL
im	NULL
.	NULL

Co	NULL
bo	NULL
-	NULL
O	NULL
ia	NULL
go	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
FeeRI-	NULL
»	NULL
y	NULL
Chain	NULL
Gene	NULL
.	NULL

Kornbluth	NULL
,	NULL
J.	NULL
,	NULL
Flomenberg	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Dupont	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

129	NULL
,	NULL
2831-2839	NULL
.	NULL

Barsumian	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Isersky	NULL
,	NULL
C.	NULL
,	NULL
Petrino	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
Siraganian	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1981	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

11	NULL
,	NULL
317-323	NULL
.	NULL

Selby	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Peterlin	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
769-776	NULL
.	NULL

MacGregor	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Caskey	NULL
,	NULL
C.	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
2365	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
,	NULL
248-252	NULL
.	NULL

Gorman	NULL
,	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
H.	NULL
B	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044~1054	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Korner	NULL
,	NULL
M.	NULL
,	NULL
Harel-Bellan	NULL
,	NULL
A.	NULL
,	NULL
Brini	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
and	NULL
Farrar	NULL
,	NULL
W.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

265	NULL
,	NULL
547-554	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
35	NULL
.	NULL

36	NULL
.	NULL

EyA	NULL
38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

K	NULL
)	NULL
1361	NULL
Anﬁel	NULL
,	NULL
P.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Imbram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Ramsorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Jonat	NULL
,	NULL
C.	NULL
,	NULL
errlich	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
729-739	NULL
Tee-Chung	NULL
}	NULL
,	NULL
l	NULL
L.	NULL
,	NULL
and	NULL
Schwartz	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
140	NULL
McDonagh	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Lin	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Lowrey	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Bodine	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
11965-11974	NULL
Faisst	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Meyer	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
3-26	NULL
Hsu	NULL
,	NULL
V.	NULL
W.	NULL
,	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Fine	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Kruisbeek	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
Baniyash	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

4	NULL
,	NULL
166-171	NULL
lfgggg	NULL
,	NULL
1843	NULL
glollers	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Renkawitz	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
.	NULL

Shen	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Batzer	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Deininger	NULL
,	NULL
P.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Evol	NULL
.	NULL

83	NULL
,	NULL
3	NULL
11-320	NULL
.	NULL

Saffer	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Thurston	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
355-364	NULL
.	NULL

Tomilin	NULL
,	NULL
N.	NULL
V.	NULL
,	NULL
Iguchi-Ariga	NULL
,	NULL
S.	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Ariga	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

263	NULL
,	NULL
69-72	NULL

